Search research articles
Contact Us
Filters
Showing results (221-230 of 526) with videos related to
Page
of 53
Sort By:
Archives of General Psychiatry
|
January 1, 1989
Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo
W K Goodman, L H Price, S A Rasmussen, et al.
Journal of Psychiatric Research
|
July 25, 2006
Effect of comorbid tics on a clinically meaningful response to 8-week open-label trial of fluoxetine in obsessive compulsive disorder
David S Husted, Nathan A Shapira, Tanya K Murphy, et al.
Journal of Clinical Psychopharmacology
|
October 1, 1993
The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder
C J McDougle, W K Goodman, J F Leckman, et al.
Psychiatry Research
|
August 1, 1993
Effects of the serotonin reuptake inhibitor fluvoxamine on yohimbine-induced anxiety in panic disorder
A W Goddard, S W Woods, D E Sholomskas, et al.
The Journal of Clinical Psychiatry
|
August 1, 1990
Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder?
W K Goodman, C J McDougle, L H Price, et al.
Biological Psychiatry
|
April 1, 1993
Acute tryptophan depletion in autistic disorder: a controlled case study
C J McDougle, S T Naylor, W K Goodman, et al.
The Psychiatric Clinics of North America
|
February 5, 2023
Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder
Samuel D Spencer, Jordan T Stiede, Andrew D Wiese, et al.
Psychiatry Research
|
December 8, 2006
Factor-analytic study of the Yale Global Tic Severity Scale
Eric A Storch, Tanya K Murphy, Melanie Fernandez, et al.
The EMBO Journal
|
July 30, 2004
ATR functions as a gene dosage-dependent tumor suppressor on a mismatch repair-deficient background
Yanan Fang, Cheng-Chung Tsao, Barbara K Goodman, et al.
Psychological Assessment
|
January 6, 2006
Reliability and validity of the Yale Global Tic Severity Scale
Eric A Storch, Tanya K Murphy, Gary R Geffken, et al.
Page
of 53
Search research articles
Search
Showing results (221-230 of 526) with videos related to
Sort By:
Page
of 53
Archives of General Psychiatry
|
January 1, 1989
Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo
W K Goodman, L H Price, S A Rasmussen, et al.
Journal of Psychiatric Research
|
July 25, 2006
Effect of comorbid tics on a clinically meaningful response to 8-week open-label trial of fluoxetine in obsessive compulsive disorder
David S Husted, Nathan A Shapira, Tanya K Murphy, et al.
Journal of Clinical Psychopharmacology
|
October 1, 1993
The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder
C J McDougle, W K Goodman, J F Leckman, et al.
Psychiatry Research
|
August 1, 1993
Effects of the serotonin reuptake inhibitor fluvoxamine on yohimbine-induced anxiety in panic disorder
A W Goddard, S W Woods, D E Sholomskas, et al.
The Journal of Clinical Psychiatry
|
August 1, 1990
Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder?
W K Goodman, C J McDougle, L H Price, et al.
Biological Psychiatry
|
April 1, 1993
Acute tryptophan depletion in autistic disorder: a controlled case study
C J McDougle, S T Naylor, W K Goodman, et al.
The Psychiatric Clinics of North America
|
February 5, 2023
Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder
Samuel D Spencer, Jordan T Stiede, Andrew D Wiese, et al.
Psychiatry Research
|
December 8, 2006
Factor-analytic study of the Yale Global Tic Severity Scale
Eric A Storch, Tanya K Murphy, Melanie Fernandez, et al.
The EMBO Journal
|
July 30, 2004
ATR functions as a gene dosage-dependent tumor suppressor on a mismatch repair-deficient background
Yanan Fang, Cheng-Chung Tsao, Barbara K Goodman, et al.
Psychological Assessment
|
January 6, 2006
Reliability and validity of the Yale Global Tic Severity Scale
Eric A Storch, Tanya K Murphy, Gary R Geffken, et al.
Page
of 53